Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8854498 | 0.67 | — | — | |
| SCHEMBL23152694 | 0.65 | CA4 (0.31) | ALDH1A1 | |
| SCHEMBL8719 | 0.65 | TSHR (0.39) | LMNATSHRALOX12ACHEKMT2A | |
| SCHEMBL7631451 | 0.65 | TSHR (0.39) | LMNATSHRALOX12ACHEKMT2A | |
| SCHEMBL55165 | 0.65 | — | — | |
| Benzene SCHEMBL28223369 | 0.63 | ALDH1A1 (0.40) | LMNATSHRALOX12ACHEKMT2A | |
| SCHEMBL38901 | 0.63 | ALDH1A1 (0.40) | LMNATSHRALOX12ACHEKMT2A | |
| Benzene SCHEMBL27879268 | 0.63 | ALDH1A1 (0.40) | LMNATSHRALOX12ACHEKMT2A | |
| SCHEMBL1778033 | 0.63 | ALDH1A1 (0.40) | LMNATSHRALOX12ACHEKMT2A | |
| SCHEMBL28741267 | 0.63 | TSHR (0.37) | LMNATSHRALOX12ACHEALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020147286-A1 | Process for producing substantially amorphous propylene-based polymers | EQUISTAR CHEMICALS, LP | 2002-10-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020147286-A1 | Process for producing substantially amorphous propylene-based polymers | GRB7, CHRM1, CPNE4 | LMNA 3780/4885TSHR 1288/4885ALOX12 750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.